Albireo Pharma (ALBO) Competitor Comparison
We are evaluating the key criteria listed to compare Albireo Pharma (ALBO) against its competitors in the Biotechnology industry.
Market Capitalization
131 / 368Gross Profits
69 / 278Total Revenue
113 / 300EBITDA
227 / 337Free Cashflow
255 / 352Quick Ratio
158 / 357Earnings per Share
326 / 359Dividend yield
0 / 6Total Cash
143 / 358Performance 3 years
53 / 368Performance 5 years
106 / 368Performance 10 years
138 / 368Linearity 3 years
297 / 368Linearity 5 years
82 / 368Linearity 10 years
130 / 368Total Rank
82 / 368Dividend Rank
339 / 368Valuation Rank
103 / 368Piotroski Rank
213 / 368Muliplier Rank
258 / 368Muliplier Rank - ALBO ranking 258 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.